Results 51 to 60 of about 672,472 (195)

Human pharmacology of narcotic antagonists.

British Journal of Clinical Pharmacology, 1979
D. Jasinski
semanticscholar   +1 more source

Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain Clinicians. [PDF]

J Anesth
Kanai A, Iseki M, Iida H, Yamaguchi S, Oiwa A, Yonekura H, Iwashita N, Ueno H, Kimura Y, Takasusuki T, Yamaguchi K, Iida S, Ikemiya H, Oya R, Sugiyama Y, Tanabe K, Taniguchi A, Hattammaru Y, Mizogami M, Yamaguchi S, Yamada K, Fukui S.   +21 more
europepmc   +1 more source

Patient Insights to Improve Naloxone Access and Decision Support. [PDF]

Perm J
Boraz R, Stumbo SP, Leitz SJ, Yarborough BJH.   +3 more
europepmc   +1 more source

Medication Prescribing Observations in Care Transitions for Incarcerated Patients. [PDF]

Hosp Pharm
Shoulders BR, Maguigan KL, Lemon SJ.
europepmc   +1 more source

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal. [PDF]

Addict Biol
Haghdoost M, LaBranche J, Roberts M, Li VW, Kim JJ, Wong JSH, Azar P.   +6 more
europepmc   +1 more source

Leveraging near-peer teaching: the impact of cognitive and social congruence on naloxone training. [PDF]

Med Educ Online
Polcyn J, VanBrackle R, Zink N, Covington K, Heboyan V, Rockich-Winston N.   +5 more
europepmc   +1 more source

Variation in naloxone and buprenorphine prescribing in LA County's safety-net system. [PDF]

J Opioid Manag
Pak L, Crowley C, Ragins K, Belani H, Kalmin M, Watkins KE.   +5 more
europepmc   +1 more source

Practical guidance for navigating buprenorphine discontinuation. [PDF]

Harm Reduct J
Sonoda K, Hilmer AB, Bello JK.
europepmc   +1 more source

Factors associated with medications for opioid use disorder (MOUD) treatment success during the pregnancy and postpartum periods: A scoping review. [PDF]

Drug Alcohol Depend
Mburu M, Masese R, Knippler ET, Watt MH, Muhirwa A, Ledbetter L, Graton M, Knettel BA.   +7 more
europepmc   +1 more source

Inpatient initiation of long-acting injectable buprenorphine for adolescents and young adults with opioid use disorder. [PDF]

J Subst Use Addict Treat
Congdon JL, Bazazi AR, Rossi MM, Stemmle M, Chang A, Lau S, Trope LA.   +6 more
europepmc   +1 more source